Innovative Solutions

From concept to final project. Deploying market-leading CDMO-technology to bring your solutions to scale.

Contract Manufacturing

Advanced CDMO services from startup to scale with capacities from 1L to >3000L and services from formulation to finishing.

Learn More

Medical Devices

In-house development and production of advanced medical devices and technologies to facilitate patient care and improve quality of life.

Learn More

Accelerator

Deploying our scalable production and funding solutions to jumpstart the next generation of medical technologies.

Learn More

Covid-19 Pandemic Response

Employing advanced American manufacturing to solve global problems, Attwill has been there every step of the way, from mass-producing isopropyl hand sanitizer, to LyoSphere COVID test kits, to development and manufacture of next-generation COVID vaccines and treatments.

Attwill – American Biomedical Manufacturing and Development

Attwill holds America’s largest medical lyophilization capacity and acts as a vital link in the domestic supply chain for critical healthcare technologies while advancing American-made, next-generation, biomedical manufacturing.

Recent News

Adventa Bioscience announces commercial launch of Trulacta

July 14, 2021

Adventa Bioscience announces commercial launch of Trulacta

AMS portfolio company Adventa Bioscience announces the commercial launch of its first product trulacta, a direct to consumer dietary supplement made from human milk.

Read More
Attwill welcomes former WI Gov. & Current UW System President Tommy Thompson

June 10, 2021

Attwill welcomes former WI Gov. & Current UW System President Tommy Thompson

Attwill was proud to host former WI governor and current president of the UW System Tommy Thomson for a roundtable discussion to improve ties between the University and UW system.

Read More
US. Sen. Tammy Baldwin visits Attwill Medical Solutions

June 1, 2021

US. Sen. Tammy Baldwin visits Attwill Medical Solutions

Attwill was proud to host U.S. Senator Tammy Baldwin (D-WI) for a roundtable discussion regarding the manufacturing life science components in the United States.

Read More
U.S. Representative Glenn Grothman visits Attwill Medical Solutions for roundtable discussion

February 19, 2021

U.S. Representative Glenn Grothman visits Attwill Medical Solutions for roundtable discussion

Attwill Medical Solutions™ was proud to host U.S. Representative Glenn Grothman for a roundtable discussion regarding the company, as well as a comprehensive facility tour.

Read More
Attwill Receives FDA 510k clearance for HaloGUARD™

October 2, 2020

Attwill Receives FDA 510k clearance for HaloGUARD™

Attwill Medical Solutions™ is pleased to disclose that its HaloGUARD™ product received FDA 510 (k) clearance in September 2020.

Read More
Operation Warp Speed participant, Vaxart, Inc. (NASDAQ:

June 25, 2020

Operation Warp Speed participant, Vaxart, Inc. (NASDAQ: "VXRT"), signs MOU with AMS for production of COVID-19 Vaccine

Vaxart, Inc. has announced it will be working with Attwill Medical Solutions™ to manufacture its revolutionary oral vaccine for COVID-19.

Read More
Adventa Bioscience launches Trulacta

January 23, 2021

Adventa Bioscience launches Trulacta

Attwill is pleased to announce the launch of portfolio company Adventa Bioscience’s first product trulacta.

Read More
Attwill partners with local distillery to produce hand sanitizer for COVID crisis

April 8, 2020

Attwill partners with local distillery to produce hand sanitizer for COVID crisis

Attwill Medical Solutions is partnering with a nearby distillery to produce and sell hand sanitizer to hospitals and essential workers.